Skip to main content
. Author manuscript; available in PMC: 2011 Jan 18.
Published in final edited form as: Transplant Proc. 1995 Feb;27(1):210–212.

Table 1.

Organ Function of Recipients With or Without Donor Bone Marrow Augmentation

Type of Transplantation n Postoperative day T. Bilirubin (mg/dL) Creatinine (mg/dl) C-Peptide (pM/ml) Insulin (U/day) No. of Patients Off Steroids
With bone marrow
 OLT 7 355 ± 103* 0.5 ± 0.3* 4
 OLT + islets 1 326 0.3 0.02 29 0
 CRT 9 395 ± 138* 1.7 ± 0.9* 4
 CRT + islets 2 411, 422 2.2, 1.9 0.44, 0.11 32,32 1
Without bone marrow
 OLT 14 235 ± 35* 0.8 ± 0.4* 8
 CRT 9 250 ± 33* 3.0 ± 1.6* 0
 HT 2 197, 197 Optimal cardiac function 0

OLT, orthotopic liver transplantation; CRT, cadaveric renal transplantation.

*

Means ± SD.